Towards targeted therapy for infant acute lymphoblastic leukaemia

Onderzoeksoutput: Bijdrage aan tijdschriftArtikel recenserenpeer review

30 Citaten (Scopus)


Despite the greatly improved treatment regimes for childhood acute lymphoblastic leukaemia (ALL) in general, resulting in long-term survival in approximately 80% of cases, current therapies still fail in >50% of ALL cases diagnosed within the first year of life (i.e. in infants). Therefore, more adequate treatment strategies are urgently needed to also improve the prognosis for these very young patients with ALL. Here we review the current acquaintance with the biology of infant ALL and describe how this knowledge may lead to innovative therapeutic approaches.

Originele taal-2Engels
Pagina's (van-tot)539-51
Aantal pagina's13
TijdschriftBritish journal of haematology
Nummer van het tijdschrift5
StatusGepubliceerd - mrt. 2006
Extern gepubliceerdJa


Duik in de onderzoeksthema's van 'Towards targeted therapy for infant acute lymphoblastic leukaemia'. Samen vormen ze een unieke vingerafdruk.

Citeer dit